-
-
-
-
-
-
-
GRI Bio, Inc (GRI) Presents Positive Pre-Clinical Data Demonstrating GRI-0621 Resolves Inflammation and Fibrosis in Bleomycin-Induced Fibrosis and Reiterates Promising Preliminary Phase 2a Clinical Re
-
-
-
-
-
-
-
GRI Bio, Inc (GRI) Raises a Total of $13.9M in Gross Proceeds Since the Beginning of 2024
-
-
-
-
-
-
-
Form S-1/A GRI BIO, Inc.
-
-
-
-
-
-
-
Form S-1/A GRI BIO, Inc.
-
66,424 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

